Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1949 2
1950 2
1953 1
1954 1
1955 2
1957 1
1958 1
1959 3
1960 3
1961 3
1962 7
1963 6
1964 6
1965 8
1966 12
1967 11
1968 8
1969 4
1970 8
1971 7
1972 3
1973 12
1974 9
1975 17
1976 7
1977 8
1978 10
1979 9
1980 4
1981 7
1982 9
1983 18
1984 5
1985 7
1986 6
1987 8
1988 10
1989 11
1990 10
1991 10
1992 15
1993 11
1994 13
1995 14
1996 12
1997 18
1998 13
1999 11
2000 20
2001 19
2002 15
2003 13
2004 21
2005 24
2006 14
2007 24
2008 25
2009 12
2010 16
2011 19
2012 40
2013 36
2014 27
2015 39
2016 50
2017 31
2018 28
2019 38
2020 35
2021 37
2022 17
Text availability
Article attribute
Article type
Publication date

Search Results

917 results
Results by year
Filters applied: . Clear all
Page 1
Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.
Ishizawa J, Zarabi SF, Davis RE, Halgas O, Nii T, Jitkova Y, Zhao R, St-Germain J, Heese LE, Egan G, Ruvolo VR, Barghout SH, Nishida Y, Hurren R, Ma W, Gronda M, Link T, Wong K, Mabanglo M, Kojima K, Borthakur G, MacLean N, Ma MCJ, Leber AB, Minden MD, Houry W, Kantarjian H, Stogniew M, Raught B, Pai EF, Schimmer AD, Andreeff M. Ishizawa J, et al. Among authors: davis re. Cancer Cell. 2019 May 13;35(5):721-737.e9. doi: 10.1016/j.ccell.2019.03.014. Epub 2019 May 2. Cancer Cell. 2019. PMID: 31056398 Free PMC article.
CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel.
Plaks V, Rossi JM, Chou J, Wang L, Poddar S, Han G, Wang Z, Kuang SQ, Chu F, Davis RE, Vega F, Bashir Z, Jacobson CA, Locke FL, Reagan PM, Rodig SJ, Lekakis LJ, Flinn IW, Miklos DB, Bot A, Neelapu SS. Plaks V, et al. Among authors: davis re. Blood. 2021 Sep 23;138(12):1081-1085. doi: 10.1182/blood.2021010930. Blood. 2021. PMID: 34041526 Free PMC article. Clinical Trial. No abstract available.
Retraction.
Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD. Davis RE, et al. Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):12069. doi: 10.1073/pnas.95.20.12069-b. Proc Natl Acad Sci U S A. 1998. PMID: 16578857 Free PMC article. No abstract available.
Ascaris.
Wang J, Davis RE. Wang J, et al. Among authors: davis re. Curr Biol. 2020 May 18;30(10):R423-R425. doi: 10.1016/j.cub.2020.02.064. Curr Biol. 2020. PMID: 32428467 Free article.
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E, Jaffe ES, Wilson WH, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pierce SK, Staudt LM. Davis RE, et al. Nature. 2010 Jan 7;463(7277):88-92. doi: 10.1038/nature08638. Nature. 2010. PMID: 20054396 Free PMC article.
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial.
Calabrese JR, Durgam S, Satlin A, Vanover KE, Davis RE, Chen R, Kozauer SG, Mates S, Sachs GS. Calabrese JR, et al. Among authors: davis re. Am J Psychiatry. 2021 Dec;178(12):1098-1106. doi: 10.1176/appi.ajp.2021.20091339. Epub 2021 Sep 23. Am J Psychiatry. 2021. PMID: 34551584 Clinical Trial.
917 results